[HTML][HTML] Strategies for targeting gene therapy in cancer cells with tumor-specific promoters

M Montaño-Samaniego, DM Bravo-Estupiñan… - Frontiers in …, 2020 - frontiersin.org
Cancer is the second cause of death worldwide, surpassed only by cardiovascular diseases,
due to the lack of early diagnosis, and high relapse rate after conventional therapies …

[HTML][HTML] CRISPR/Cas: advances, limitations, and applications for precision cancer research

Y Yang, J Xu, S Ge, L Lai - Frontiers in medicine, 2021 - frontiersin.org
Cancer is one of the most leading causes of mortalities worldwide. It is caused by the
accumulation of genetic and epigenetic alterations in two types of genes: tumor suppressor …

[HTML][HTML] Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies

M Xu, T Feng, B Liu, F Qiu, Y Xu, Y Zhao, Y Zheng - Theranostics, 2021 - ncbi.nlm.nih.gov
As extracellular vesicles secreted by cells, exosomes are intercellular signalosomes for cell
communication and pharmacological effectors. Because of their special properties, including …

[HTML][HTML] Neural stem cells of the subventricular zone as the origin of human glioblastoma stem cells. Therapeutic implications

ER Matarredona, AM Pastor - Frontiers in oncology, 2019 - frontiersin.org
Human glioblastoma is the most aggressive type of primary malignant brain tumors.
Standard treatment includes surgical resection followed by radiation and chemotherapy but …

Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery

C De Masi, P Spitalieri, M Murdocca, G Novelli… - Human genomics, 2020 - Springer
Human-induced pluripotent stem cells (hiPSCs) and CRISPR/Cas9 gene editing system
represent two instruments of basic and translational research, which both allow to acquire …

Nanomaterials: small particles show huge possibilities for cancer immunotherapy

Z Chen, Z Yue, K Yang, S Li - Journal of Nanobiotechnology, 2022 - Springer
With the economy's globalization and the population's aging, cancer has become the
leading cause of death in most countries. While imposing a considerable burden on society …

Recent advances in nanotherapeutic strategies for spinal cord injury repair

YH Song, NK Agrawal, JM Griffin, CE Schmidt - Advanced drug delivery …, 2019 - Elsevier
Spinal cord injury (SCI) is a devastating and complicated condition with no cure available.
The initial mechanical trauma is followed by a secondary injury characterized by …

CRISPR/Cas9: transcending the reality of genome editing

S Chira, D Gulei, A Hajitou, AA Zimta… - … Therapy-Nucleic Acids, 2017 - cell.com
With the expansion of the microbiology field of research, a new genome editing tool arises
from the biology of bacteria that holds the promise of achieving precise modifications in the …

Cancer's epigenetic drugs: where are they in the cancer medicines?

S Ghasemi - The pharmacogenomics journal, 2020 - nature.com
Epigenetic modulation can affect the characteristics of cancers. Because it is likely to
manipulate epigenetic genes, they can be considered as potential targets for cancer …

[HTML][HTML] Glioblastoma: new therapeutic strategies to address cellular and genomic complexity

X Cai, ME Sughrue - Oncotarget, 2018 - ncbi.nlm.nih.gov
Glioblastoma (GBM) is the most invasive and devastating primary brain tumor with a median
overall survival rate about 18 months with aggressive multimodality therapy. Its unique …